IMIDAZOLE 4-CARBOXAMIDE COMPOUNDS WITH ADENOSINE DEAMINASE INHIBITING ACTIVITY

Details for Australian Patent Application No. 2003214646 (hide)

Owner FUJISAWA PHARMACEUTICAL Co., Ltd.

Inventors KATO,Takeshi; NAKAMURA, Katsuya; TSUJI, Kiyoshi; TERASAKA, Tadashi; KONISHI, Nobukiyo

Pub. Number AU-A-2003214646

PCT Number PCT/JP03/01459

PCT Pub. Number WO2003/068768

Priority PS0581 15.02.02 AU

Filing date 12 February 2003

Wipo publication date 4 September 2003

International Classifications

C07D 405/06 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61P 037/06 Drugs for immunological or allergic disorders

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 031/423 - condensed with carbocyclic rings

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): PS0581 15.02.02 AU

2 October 2003 Application Open to Public Inspection

  Published as AU-A-2003214646

4 November 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003214647-SECURITY DEVICE AND SECURITY SYSTEM

2003214645-LONG PENTRAXIN PTX3 FUNCTIONAL DERIVATIVES FOR PREPARING AN AUTOLOGOUS VACCINE FOR THE TREATMENT OF TUMOURS